Effects of AVX-470, an Oral, Locally Acting Anti-Tumour Necrosis Factor Antibody, on Tissue Biomarkers in Patients with Active Ulcerative Colitis.
Saved in:
| Title: | Effects of AVX-470, an Oral, Locally Acting Anti-Tumour Necrosis Factor Antibody, on Tissue Biomarkers in Patients with Active Ulcerative Colitis. |
|---|---|
| Authors: | Hartman DS; Avaxia Biologics, Inc., Lexington, MA, USA., Tracey DE; Avaxia Biologics, Inc., Lexington, MA, USA., Lemos BR; Avaxia Biologics, Inc., Lexington, MA, USA., Erlich EC; Avaxia Biologics, Inc., Lexington, MA, USA., Burton RE; Avaxia Biologics, Inc., Lexington, MA, USA., Keane DM; Avaxia Biologics, Inc., Lexington, MA, USA., Patel R; Avaxia Biologics, Inc., Lexington, MA, USA., Kim S; Avaxia Biologics, Inc., Lexington, MA, USA., Bhol KC; Avaxia Biologics, Inc., Lexington, MA, USA., Harris MS; Avaxia Biologics, Inc., Lexington, MA, USA., Fox BS; Avaxia Biologics, Inc., Lexington, MA, USA bsfox@comcast.net. |
| Source: | Journal of Crohn's & colitis [J Crohns Colitis] 2016 Jun; Vol. 10 (6), pp. 641-9. Date of Electronic Publication: 2016 Jan 22. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101318676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1876-4479 (Electronic) Linking ISSN: 18739946 NLM ISO Abbreviation: J Crohns Colitis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1876-4479 |
|---|---|
| DOI: | 10.1093/ecco-jcc/jjw026 |
